Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of DNA aptamers for visualization of glial brain tumors and detection of circulating tumor cells.
Kichkailo AS, Narodov AA, Komarova MA, Zamay TN, Zamay GS, Kolovskaya OS, Erakhtin EE, Glazyrin YE, Veprintsev DV, Moryachkov RV, Zabluda VV, Shchugoreva I, Artyushenko P, Mironov VA, Morozov DI, Khorzhevskii VA, Gorbushin AV, Koshmanova AA, Nikolaeva ED, Grinev IP, Voronkovskii II, Grek DS, Belugin KV, Volzhentsev AA, Badmaev ON, Luzan NA, Lukyanenko KA, Peters G, Lapin IN, Kirichenko AK, Konarev PV, Morozov EV, Mironov GG, Gargaun A, Muharemagic D, Zamay SS, Kochkina EV, Dymova MA, Smolyarova TE, Sokolov AE, Modestov AA, Tokarev NA, Shepelevich NV, Ozerskaya AV, Chanchikova NG, Krat AV, Zukov RA, Bakhtina VI, Shnyakin PG, Shesternya PA, Svetlichnyi VA, Petrova MM, Artyukhov IP, Tomilin FN, Berezovski MV. Kichkailo AS, et al. Among authors: zukov ra. Mol Ther Nucleic Acids. 2023 Mar 24;32:267-288. doi: 10.1016/j.omtn.2023.03.015. eCollection 2023 Jun 13. Mol Ther Nucleic Acids. 2023. PMID: 37090419 Free PMC article.
Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry.
Tsimafeyeu I, Shatkovskaya O, Krasny S, Nurgaliev N, Varlamov I, Petkau V, Safina S, Zukov R, Mazhbich M, Statsenko G, Varlamov S, Novikova O, Zaitsev I, Moiseyev P, Rolevich A, Evmenenko A, Popova I, Kaidarova D, Vladimirova L. Tsimafeyeu I, et al. Cancer Rep (Hoboken). 2021 Jun;4(3):e1331. doi: 10.1002/cnr2.1331. Epub 2020 Dec 25. Cancer Rep (Hoboken). 2021. PMID: 33369240 Free PMC article.
Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.
Tjulandin S, Demidov L, Moiseyenko V, Protsenko S, Semiglazova T, Odintsova S, Zukov R, Lazarev S, Makarova Y, Nechaeva M, Sakaeva D, Andreev A, Tarasova A, Fadeyeva N, Shustova M, Kuryshev I. Tjulandin S, et al. Eur J Cancer. 2021 May;149:222-232. doi: 10.1016/j.ejca.2021.02.030. Epub 2021 Apr 17. Eur J Cancer. 2021. PMID: 33872982 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
[DNA aptamers selection for breast cancer].
Zamay GS, Belayanina IV, Zamay AS, Komarova MA, Krat AV, Eremina EN, Zukov RA, Sokolov AE, Zamay TN. Zamay GS, et al. Among authors: zukov ra. Biomed Khim. 2016 May;62(4):411-7. doi: 10.18097/PBMC20166204411. Biomed Khim. 2016. PMID: 27562994 Russian.
DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma.
Zamay GS, Ivanchenko TI, Zamay TN, Grigorieva VL, Glazyrin YE, Kolovskaya OS, Garanzha IV, Barinov AA, Krat AV, Mironov GG, Gargaun A, Veprintsev DV, Bekuzarov SS, Kirichenko AK, Zukov RA, Petrova MM, Modestov AA, Berezovski MV, Zamay AS. Zamay GS, et al. Among authors: zukov ra. Mol Ther Nucleic Acids. 2017 Mar 17;6:150-162. doi: 10.1016/j.omtn.2016.12.004. Epub 2016 Dec 31. Mol Ther Nucleic Acids. 2017. PMID: 28325282 Free PMC article.
24 results